The educational tools, resources, and news curated for those searching for peer-reviewed, clinical evidence on cannabinoids.

Clinician and Patient Discuss Cannabinoids

AES Live Event: Straight Talk: The Intersection of Clinician and Patient Perspectives on Cannabinoids

Learn potential mechanisms for cannabinoids, clinical trial updates, and the strategies for communicating risk/benefit to families and caregivers.

Pharmacist Grabbing Prescription Medication

Cannabinoids in Epilepsy: New Horizons for Improving the Management of Severe Seizure Disorders

Updates pharmacists on the medical applications of pharmacologic agents derived from cannabidiol (CBD).

Eye Glasses Resting on Book About Cannabinoid-Based Medicine

Cannabidiol: A Tale of Two Products

An educational program that equips pharmacists with current and useful information regarding cannabidiol.

Healthcare Practitioner Discusses Cannabinoid-Based Treatment with Caregiver

Cannabinoid Discussion Guide

Know what questions to ask your healthcare practitioners and what to consider when thinking about cannabinoid-based treatments.

Trichomes on Purple Cannabis Flower

Medical Marijuana and Dispensary Products Fact Sheet

Know what the differences are between FDA-approved and non–FDA-approved medications.

Pharmacists Discussing Prescription Medication

The FDA Approval Process

FDA-approved medicines are available by prescription in both specialty and/or retail pharmacies, not dispensaries. Download to learn the difference between FDA-approved and non–FDA approved cannabinoid products.

Scientists Testing Synthetic Cannabinoids

WHO Recommends CBD Alone Should Not Be a Scheduled Substance

World Health Organization’s (WHO) Expert Committee on Drug Dependence concluded that cannabidiol (in its pure state) does not appear to have abuse potential or cause harm.

Dictionary Opened to Definition of Innovation

Glossary of Cannabinoid Terms

This brochure (developed by Greenwich Biosciences, CEWG, and a patient advocate) offers a quick overview of many of the cannabinoid terms in use today and non–FDA approved medications.

Cannabis Leaves

A Disease Awareness Foundation’s Quiz: 10 Things to Know About Medical Cannabis

Test your knowledge of cannabinoids.

FDA Warning Letter About Cannabinoid Products

Warning Letters Issued by the FDA Regarding Cannabinoid Products

As part of the FDA’s efforts to protect consumers from health fraud, warning letters have been issued to dispensing companies for illegally selling products online that claim to prevent, diagnose,...Read More

Large Stack of Colorful Books

Continuing Education on Cannabinoids

Cannabinoid Clinical will only provide links to CME/CE programs from ACCME-accredited providers that are offered with no cost to the viewer. Medscape CME/CE: The Basis of Cannabinoid Therapeutics...Read More

Cannabis Products at a Marijuana Dispensary

Pharmaceutical-vs-Dispensary-Sourced Cannabinoids: What's the Difference?

An online activity for neurologists, pediatricians, primary care physicians, nurses, and pharmacists interested in increasing their knowledge of how to differentiate pharmaceutical-grade from dispensary-sourced cannabinoids, including...Read More

Health Effects

Health Effects of Cannabis and Cannabinoids Report

The health effects of cannabis and cannabinoids as studied by the National Academies of Sciences, Engineering, and Medicine’s expert committee.

Handbook of Cannabis Book Cover

Handbook of Cannabis by Roger Pertwee

A 700+ page book by leading researchers from around the world, covering history, pharmacology, potential therapeutic uses, and clinical research of cannabinoids.

Labeling Accuracy of Dispensary Products

JAMA: Labeling Accuracy of Cannabidiol Extracts

The Journal of the American Medical Association (JAMA) published research letters on the labeling accuracy of products sold in dispensaries, online, or in brick-and-mortar shops.

Young Woman Lighting a Joint

Current Cannabis Controversies

A review of issues facing cannabinoid medicine and research by Ethan B. Russo published in Frontiers in Pharmacology.

Hands of a Man Holding Cannabis Flower

Does the Passage of the 2018 Farm Bill Legalize Non–FDA Approved Hemp-Derived Cannabinoid Products?

It is not fully clear when hemp-derived cannabinoid products will be federally legal to be sold or how they will be regulated.

Drug Interactions

Importance of Monitoring Drug Interactions Between Medications and Cannabinoid Products

Based on the 4 FDA-approved cannabinoid drugs, these posters provide a quick overview, for the pharmacist and the patient, of possible drug interactions between medications and cannabis products along with possible side effects.

The information is brought to you by Greenwich Biosciences in partnership with the American College of the Apothecaries and Pharmacists Planning Services Inc.